BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc.’s (NYSE: KG) AtroPen® Auto-Injector (atropine injection) has been designated a Qualified Anti-Terrorism Technology under the Department of Homeland Security’s (DHS) Support Anti-Terrorism by Fostering Effective Technologies (SAFETY) Act of 2002. The DHS has also certified AtroPen® as an “Approved Product for Homeland Security” under the SAFETY Act.
